AURORA CANNABIS INC(ACB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ACB Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for AURORA CANNABIS INC (ACB), a Healthcare sector company. ACB is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of ACB by reported 13-F value include GOLDMAN SACHS GROUP, Toroso Investments, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. ACB trades on the Nasdaq exchange and files with the SEC under CIK 1683541. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AURORA CANNABIS INC directly from SEC EDGAR.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
Total Assets
-22.8% YoY| Metric | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | — | $221.3M -9.8% | $245.3M -8.7% | $268.7M +9.4% | $245.5M +344.8% | $55.2M |
| Total Assets | $837.3M -22.8% | $1.08B -58.4% | $2.60B -6.3% | $2.78B -49.4% | $5.50B +191.5% | $1.89B |
Get alerted when ACB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for AURORA CANNABIS INC including:
Top Institutional Holders of ACB
GOLDMAN SACHS GROUP INC
$3.8M1,350,837 shToroso Investments, LLC
$3.5M1,264,494 shRENAISSANCE TECHNOLOGIES LLC
$2.2M784,955 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$807.7K289,500 shNATIONAL BANK OF CANADA /FI/
$672.5K241,055 shMORGAN STANLEY
$671.5K240,698 shNATIONAL BANK OF CANADA /FI/
$670.2K2,402 shCITADEL ADVISORS LLC
$523.7K187,700 shCITADEL ADVISORS LLC
$513.6K184,100 shUBS Group AG
$495.4K177,561 sh
| Fund | Value | Shares |
|---|---|---|
| GOLDMAN SACHS GROUP INC | $3.8M | 1,350,837 |
| Toroso Investments, LLC | $3.5M | 1,264,494 |
| RENAISSANCE TECHNOLOGIES LLC | $2.2M | 784,955 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $807.7K | 289,500 |
| NATIONAL BANK OF CANADA /FI/ | $672.5K | 241,055 |
| MORGAN STANLEY | $671.5K | 240,698 |
| NATIONAL BANK OF CANADA /FI/ | $670.2K | 2,402 |
| CITADEL ADVISORS LLC | $523.7K | 187,700 |
| CITADEL ADVISORS LLC | $513.6K | 184,100 |
| UBS Group AG | $495.4K | 177,561 |
More Healthcare Companies
View all Healthcare →Put ACB on your watchlist
Track score changes the day AURORA CANNABIS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ACB a good stock to buy?
13F Pro's AI-powered analysis of AURORA CANNABIS INC (ACB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACB are available on the ACB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ACB is classified as a small company.
Which hedge funds own ACB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AURORA CANNABIS INC's investment landscape.